TAGLIAFERRI MARY has filed 5 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 3495 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on June 11, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | TAGLIAFERRI MARY | Director | A | Common Stock | 3495 | $0.00 | 8,155.0000 | 43,779,456 | 75.00% | 0.01% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | TAGLIAFERRI MARY | Director | A | Employee Stock Option (right to buy) | 14545 | $0.00 | 14,545.0000 | 43,779,456 | 9999.99% | 0.03% |
| March 12, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | TAGLIAFERRI MARY | Director | A | Common Stock | 4660 | $0.00 | 4,660.0000 | 43,645,388 | 9999.99% | 0.01% |
| March 12, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | TAGLIAFERRI MARY | Director | A | Stock Option (right to buy) | 27900 | $0.00 | 27,900.0000 | 43,645,388 | 9999.99% | 0.06% |
| Jan. 31, 2024 | ENZO BIOCHEM INC | $ENZB | TAGLIAFERRI MARY | Director | A | Common Stock | 79365 | $0.00 | 312,383.0000 | 50,184 | 34.06% | 100.00% |